The Role of Corticosteroids in IgA Vasculitis
Corticosteroids are a mainstay of treatment for moderate to severe IgA vasculitis, particularly when organ involvement is present. These medications reduce inflammation and suppress the overactive immune response that drives symptoms.
Patients with significant abdominal pain, gastrointestinal bleeding, severe joint involvement, or kidney inflammation are often treated with corticosteroids to reduce immune-mediated damage. The therapy works by inhibiting inflammatory pathways, limiting immune cell activation, and promoting symptom relief.
Treatment is carefully tailored to balance effectiveness with potential side effects. Short-term use typically controls acute inflammation without major complications, while long-term or high-dose therapy requires close monitoring for issues such as hypertension, hyperglycemia, or infection risk.
Corticosteroid therapy is often combined with supportive care, including hydration, pain management, and monitoring of renal function. Early initiation in severe cases can prevent complications, shorten disease duration, and improve patient comfort.
Patient education is critical. Understanding the purpose of corticosteroid therapy, potential side effects, and the importance of adherence ensures safe and effective treatment.